A Long Term Follow up Study of Patients Who Have Completed the PEP005-020 Study
Completed
Conditions studied: Actinic Keratosis
In brief
This study is designed to follow up patients, who have achieved complete clearance of AK lesions (lesion count of 0) at Day 57 in the PEP005-020 study, over a 12 month period to assess both recurrence of Actinic Keratosis (AK) lesions and long term safety in the selected treatment area.
Key facts
- Study ID
- NCT00952783
- Run by
- Peplin
- People needed
- 98
- Starts
- 2009-07-01
- Expected to finish
- 2010-10-01
- Last updated by the study team
- 2015-03-26
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Park Avenue Dermatology — Orange Park, Florida, United States
- Medaphase Inc — Newnan, Georgia, United States
- Gwinnett Clinical Research Centre — Snellville, Georgia, United States
- Michigan Center for Research Corp — Clinton Twp, Michigan, United States
- Henry Ford Health Systems — Detroit, Michigan, United States
- Dermatology Associates of Rochester — Rochester, New York, United States
- Oregon Health and Science University — Portland, Oregon, United States
- Dermatology Research Associates — Nashville, Tennessee, United States
- Dematology on Ward — Adelaide, South Australia, Australia
- Dermatology Institute of Victoria — Melbourne, Victoria, Australia
- St John of God Dermatology — Subiaco, Western Australia, Australia
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.